Life Insurance
Consensus Index

AI Consensus Fit Review

Transamerica Level-Benefit Final Expense Insurance Fit Review

Transamerica is a good fit for Level-Benefit Final Expense Insurance, with two of seven platforms rating it "strong" and five rating it "good." Six of the seven platforms named Transamerica during the ranking stage, giving it an 85.7% share of included platform responses and an average listed rank of 3.0.

Research: 2026-09-227 usable platform responsesRead the methodology ↗

Share

Answer Capsule

Transamerica is a good fit for Level-Benefit Final Expense Insurance, with two of seven platforms rating it "strong" and five rating it "good." Six of the seven platforms named Transamerica during the ranking stage, giving it an 85.7% share of included platform responses and an average listed rank of 3.0. The strongest reason to consider it is a clearly identifiable level-benefit product line — FE Express Solution and Immediate Solution — that pairs guaranteed level premiums with simplified, exam-free underwriting and fast digital decisions. The main limitation is that Transamerica also sells graded products (Easy Solution and a graded FE Express tier), and health-based tier assignment can push an applicant into a two-year waiting period that defeats the level-benefit objective.

Research Snapshot

FieldDetail
Platform mentions in ranking stage6 of 7 platforms (anthropic, google, grok, kimi, openai, perplexity)
Share of included platform responses85.7%
Average listed rank3.0
Best listed rank2 (grok, kimi)
Relevant product/model/planFE Express Solution (Level-Benefit tier); Final Expense Immediate Solution and 10-Pay Solution
Overall use-case fitStrong (2 platforms); Good (5 platforms) — 7 platforms analyzed
Research date2026-09-22

Why Transamerica Qualified for This Study

Questions This Section Answers

  • Is Transamerica a good choice for level-benefit final expense insurance with simplified underwriting?
  • Why did AI platforms rank Transamerica for level-benefit final expense coverage?

Transamerica qualified because six of seven platforms independently named it as a carrier worth recommending for a buyer who wants a level death benefit, is willing to complete simplified underwriting, and wants a reputable carrier with clear policy guarantees. Its average listed rank was 3.0, with grok and kimi placing it second [1].

The qualification rests on three things the platforms could point to in writing: named level-benefit products, a guaranteed level premium structure, and simplified issue underwriting without a medical exam [1]. Independent 2026 rate analyses also placed Transamerica among the lower-cost final expense carriers in sample scenarios, which supported the "reasonable premiums" criterion [8].

Carrier reputation was a secondary qualifier. Transamerica is rated A (Excellent) by A.M. Best, operates as part of the Aegon group, and has been in business since 1904 or 1928 depending on the source cited [10]. One platform noted that an A rating sits one tier below the A+ held by some mutual carriers, which matters for very long-term permanent coverage [14].

The Product, Model, Plan, or Service Most Relevant to Level-Benefit Final Expense Insurance

Questions This Section Answers

  • Which Transamerica plan should a buyer choose if they need a level death benefit from day one?
  • Is Transamerica FE Express Solution a level-benefit or graded-benefit product?
  • How much coverage does Transamerica Immediate Solution offer compared with FE Express Solution?

The relevant Transamerica products are FE Express Solution (level-benefit tier) and Final Expense Immediate Solution, including its 10-Pay option. Buyers who need a level benefit should avoid Easy Solution and the graded FE Express tier [15].

Transamerica's published product guide identifies Immediate Solution and 10-Pay Solution as guaranteed-benefit products with level premiums, while Easy Solution is identified as graded [15]. The official final expense page describes simplified issue whole life with guaranteed level premiums and coverage from $1,000 to $50,000 for ages 0–85, with a $25,000 maximum face amount for Easy Solution at ages 18–80 (official:C1).

FE Express Solution is the newer digital offering. Transamerica's announcement describes guaranteed level premiums, permanent lifetime protection, a digital application, and up to $50,000 for qualified applicants [19]. Independent reviews describe the Express tier as providing an immediate level death benefit from the first day of the policy for qualifying applicants, with a graded version available for higher-risk individuals [21].

Coverage limits are reported inconsistently. U.S. News lists $5,000–$100,000 for FE Express Solutions and $1,000–$50,000 for FE Immediate Solution [24]. Other sources cap FE Express at $50,000 [20]. One platform flagged this as an unresolved conflict rather than picking a number [27].

What the AI Platforms Agreed About

Questions This Section Answers

  • Do AI platforms agree that Transamerica offers a true level death benefit from day one?
  • Is Transamerica considered competitively priced for level-benefit final expense insurance?

Agreement was strong, though not unanimous, on four points.

Level-benefit products exist and are identifiable. All seven platforms pointed to FE Express Solution and/or Immediate Solution as the level-benefit options, and all seven warned that Easy Solution is graded and should be avoided when an immediate full natural-death benefit is required [28].

Premiums are guaranteed level. Platforms consistently described level premiums that do not increase with age as long as required premiums are paid. Immediate Solution premiums are designed to remain level to age 121; 10-Pay Solution premiums are level for 10 years [28].

Underwriting is simplified, not guaranteed issue. Transamerica markets simplified underwriting with health questions and no medical exam, with potential same-day or 10-minute decisions for qualifying applicants [38]. Multiple platforms stressed that approval is not guaranteed and that Transamerica reserves the right to request additional underwriting [42].

Pricing is competitive in modeled comparisons. Independent 2026 analyses reported Transamerica final expense pricing below the analyzed national average, with the strongest reported value in the $10,000–$25,000 range [44]. MoneyGeek sample figures included $35 per month for a 50-year-old woman and $44 per month for a 50-year-old man, and roughly $78 for women and $60 for men at age 70 [45]. These are modeled averages, not quotes.

Where the AI Platforms Disagreed or Were Uncertain

Questions This Section Answers

  • What are the biggest uncertainties about Transamerica level-benefit final expense coverage?
  • Does Transamerica have any complaint or claims-experience concerns buyers should weigh?

Maximum face amount. Sources conflict between $50,000 and $100,000 for FE Express Solution, and one platform noted the higher figure may apply only to younger applicants [48]. This is unresolved in the supplied evidence.

FE Express rollout status. One source described the initial FE Express rollout as expected by the end of 2026, which leaves current availability as of the September 2026 research date unconfirmed [51].

Complaint experience. One platform reported a NAIC complaint index of 3.86, nearly four times the industry baseline, while noting this likely reflects Transamerica's larger indexed universal life and term business rather than final expense specifically [52]. No other platform raised complaint data, so this is a single-platform finding.

Tier assignment for natural death. One platform stated that whether Preferred and Standard tiers provide a true immediate level benefit from day one for all causes of death is not explicitly stated in public materials, even though accidental death pays the full amount immediately [53].

Product naming. The relationship between the FE Express name and current state-specific policy forms is not fully clear from the cited materials, and some official product materials are older or agent-facing [55].

Financial strength ratings. One platform could not confirm current A.M. Best ratings from the sources it reviewed, while others cited an A (Excellent) rating [57].

Use-Case-Specific Features and Capabilities

Questions This Section Answers

  • What features does Transamerica offer for level-benefit final expense buyers who want fast approval?
  • Does Transamerica level-benefit final expense coverage build cash value?

Level death benefit. Immediate Solution and 10-Pay Solution are documented as guaranteed-benefit products, while Easy Solution is graded [60]. The FE Express Express tier is described as providing an immediate level death benefit from the first day of the policy for qualifying applicants [61].

Premium structure. Immediate Solution premiums are designed to remain level to age 121; 10-Pay Solution premiums are level for 10 years [60]. One source described premiums as payable during the life of the insured prior to the policy anniversary at age 100, with the contract endowing at age 121 [63].

Underwriting. Simplified issue with health questions and no medical exams, with electronic application and potential same-day decisions. The digital application is not available in New York according to the cited official page [65].

Coverage amounts and issue ages. The published portfolio guide lists issue ages of 0–85 and face amounts from $1,000 up to age-based maximums: generally $50,000 through age 55, $40,000 at ages 56–65, $30,000 at ages 66–75, and $25,000 at ages 76–85, with state variations [60]. One platform described this as the sharpest age-based step-down among the carriers it reviewed, compared with a competitor offering a flat $50,000 to age 85 [68].

Cash value. FE Express Solution builds cash value over time on a whole life basis, and the cash value is tax-deferred and can be borrowed against [69]. One platform noted a variable policy loan rate not to exceed 8% [68].

Riders and living benefits. Transamerica describes an accelerated death benefit for qualifying conditions such as nursing-home care, where available, plus optional riders [65]. One source described an accelerated death benefit of up to 75% of the current death benefit to a maximum of $250,000 per life with a $10,000 minimum payment [70]. A Concierge Planning Rider is described as available at no additional cost in some materials, subject to state approval, not available in Oregon, and offered as a service outside the policy in Florida [71]. One platform reported that Accidental Death and Children's/Grandchildren's riders are available only on Immediate Solution [68].

Claims. One source reported that Transamerica can pay up to $25,000 of the death benefit quickly for immediate funeral expenses [74]. Another described expedited payment within roughly 72 hours of receiving required paperwork in good order [68].

Pricing, Fees, Contracts, and Ongoing Costs

Questions This Section Answers

  • How much does Transamerica level-benefit final expense insurance cost per month?
  • Are there application fees or cancellation terms a buyer should confirm before signing?

Exact premiums are not publicly stated on the cited official product page and depend on age, sex, tobacco status, health, face amount, payment mode, state, and underwriting outcome [75]. Pricing confidence across platforms was low to moderate.

Published or modeled figures include:

  • $40–$60 per month for a $10,000 policy for a 60-year-old woman in good health, from Transamerica's own example [78].
  • $35 per month for a 50-year-old woman and $44 per month for a 50-year-old man, nonsmokers, from a 2026 independent comparison [79].
  • Approximately $78 per month for women and $60 for men at age 70 in one analysis, and $78–$103 per month for 70-year-olds at $15,000 coverage in another [81].
  • $41 per month for a 65-year-old woman and $54 per month for a 65-year-old man for $10,000 Immediate Solution Preferred, rising to $71 and $97 respectively at age 75 [83].
  • Approximately $97 per month for a $25,000 policy for a woman and $130 per month for a man under stated assumptions in a 2026 independent comparison [84].

These are modeled or illustrative figures and should not be treated as Transamerica quotes.

On fees and contract terms: no separate application fee was identified in the cited sources [75]. Rider charges, modal-payment differences, reinstatement costs, and policy-service charges were not verified. One platform reported a 30-day free-look period for replacement transactions and monthly or annual payment modes only on FE Express, with monthly, quarterly, semiannual, and annual modes on the traditional portfolio [83]. Another platform stated that free-look, lapse, reinstatement, surrender, and nonforfeiture provisions were not verified from public sources [75]. One platform noted a standard two-year contestability period [86].

Best Suited For

Questions This Section Answers

  • Who is Transamerica level-benefit final expense insurance best for?
  • Is Transamerica a good fit for a buyer who wants fast digital approval without a medical exam?

Transamerica is best suited for applicants who are willing to answer health questions and undergo simplified underwriting rather than seek guaranteed-issue coverage, and who want permanent whole life coverage with a stated death benefit available from policy inception, subject to policy terms and exclusions [87].

It also fits buyers who value level premiums, relatively small face amounts, digital application capability, and optional accelerated-benefit riders [89]. One platform specifically highlighted applicants with conditions such as congestive heart failure without a defibrillator or diabetic neuropathy with insulin use who need immediate coverage, and active individuals who may benefit from an activity-based rate improvement [91].

Buyers who want a nationally recognized carrier and are comfortable working with an agent or broker are also a fit, since policies are distributed primarily through licensed independent agents and broker networks [92].

Probably Not Best Suited For

Questions This Section Answers

  • Who should not choose Transamerica for level-benefit final expense insurance?
  • Is Transamerica a poor fit for applicants who need guaranteed acceptance?

Transamerica is probably not the best fit for applicants who require guaranteed acceptance regardless of health, because simplified issue is not guaranteed issue and health history can affect approval, classification, or offer [94].

It is also a weaker fit for buyers who need a public, directly comparable premium quote before applying, since exact rates are not publicly transparent and must be quoted [94]. Buyers who need coverage above the product's age-based maximums, or who live in a jurisdiction where the selected form is unavailable, should look elsewhere [98].

One platform reported that four or more medical conditions rated Standard or Graded triggers an automatic decline, which is stricter than some competitors, and that there is no guaranteed-issue product within Transamerica's lineup [100]. Another reported that diabetes is rated Standard rather than Preferred on the traditional portfolio, so buyers whose primary condition is diabetes may find better rates elsewhere [100].

Buyers considering Easy Solution while requiring a full natural-death benefit immediately are also a poor fit for that specific product [98].

When Another Option May Be Better

Questions This Section Answers

  • When is a different carrier a better choice than Transamerica for level-benefit final expense insurance?
  • What should a buyer do if they only qualify for graded coverage?

Another option may be better in several defined situations.

Guaranteed issue is required. If the applicant cannot qualify through simplified underwriting, a guaranteed-issue carrier is the better path [102].

Lowest absolute premium is the priority. Multiple platforms noted that Transamerica rates can run slightly higher than some competitors for certain age groups, and that buyers seeking the absolute lowest premium should compare alternatives [105].

Higher coverage or broader state availability is needed. Buyers who need coverage above Transamerica's age-based maximums, or who need a form unavailable in their state, should compare other level-benefit carriers [108].

A specific rider, face amount, payment period, or contract provision is required. If Transamerica cannot provide it in the buyer's state, a different carrier is the answer [102].

New York residency. FE Express Solution is reported as not available in New York, and one platform noted the traditional portfolio requires paper applications there [109].

Complaint experience is a priority. One platform recommended comparing carriers with lower complaint ratios and stronger claims experience if that outweighs price [111].

Questions to Verify Before Buying

Questions This Section Answers

  • What should a buyer confirm with Transamerica before signing a level-benefit final expense contract?
  • How can a buyer confirm they are being quoted the level-benefit tier rather than a graded product?

Confirm the following in writing before signing:

  1. Is the offered policy specifically Immediate Solution, 10-Pay Solution, or FE Express Level Benefit, rather than Easy Solution or a graded FE Express tier [112]?
  2. Does the issued contract pay the full stated death benefit for covered natural death from the policy date, subject to the contract's exclusions and contestability provisions [112]?
  3. What is the exact monthly or annual premium, payment mode, underwriting class, and guaranteed premium duration [115]?
  4. Is the policy available in the buyer's state, and which Transamerica issuing company and policy form will issue it [115]?
  5. Are an exam, labs, prescription records, attending-physician statements, or additional underwriting requirements possible despite the simplified application [115]?
  6. What are the first-two-year exclusions or limitations, if any, and how are accidental death and suicide treated [115]?
  7. What happens to the death benefit and cash value if premiums are missed, the policy lapses, or the policy is surrendered [115]?
  8. Which riders are available, what do they cost, and do accelerated benefits reduce the death benefit or cash value [115]?
  9. What are the free-look period, reinstatement terms, nonforfeiture options, and beneficiary-claim requirements [115]?
  10. Is the quoted premium guaranteed for the selected payment period, and are any policy fees or modal charges included [115]?

Final AI Consensus Verdict

Transamerica is a good fit for level-benefit final expense insurance, with two platforms rating it strong and five rating it good. Six of seven platforms named it during ranking, at an average listed rank of 3.0 and a best rank of 2.

The consensus case is straightforward: Transamerica sells identifiable level-benefit products with guaranteed level premiums, simplified underwriting without a medical exam, and competitive modeled pricing, from a carrier rated A (Excellent) by A.M. Best. The consensus caution is equally clear: the same product family includes graded options, and health-based tier assignment can produce a two-year waiting period that contradicts the buyer's core requirement.

The recommendation is conditional. Buyers should confirm the exact product tier, current state availability, current FE Express policy forms, exclusions, and contract terms through a personalized quote and policy review before purchasing. Platform agreement in this study reflects how AI systems described Transamerica's fit; it does not establish product quality or guarantee any outcome.

How This Review Was Produced

This review was produced from seven AI platform responses to a single buyer prompt about level-benefit final expense insurance. Each platform returned a fit assessment, use-case findings, pricing and terms, limitations, and questions to verify. The research date for this study is 2026-09-22.

Platform mentions in the ranking stage count only platforms that named Transamerica during ranking discovery. All seven included platforms evaluated fit, but one did not name Transamerica in the ranking stage, so the mention count is six.

Citations are platform-reported evidence, not independently verified facts. Company-owned sources are distinguished from independent sources in the Sources section. Where a platform supplied no citation for a factual claim, the claim is labeled platform-reported or unverified.

Methodology Limitations

  • The supplied URLs were collected from platform responses and were not independently validated by the writer stage.
  • Platform-reported research dates differ from the authoritative run date. Six platforms reported 2026-09-23 and one reported 2026-02-14, while the study research date is 2026-09-22. Platform-reported dates are provenance metadata and do not independently prove freshness.
  • One platform ran without search enabled, so its claims require explicit verification before being described as current facts.
  • Conflicting product names, coverage limits, and pricing were not resolved by guessing. Where sources conflicted, the conflict is described and buyers are directed to verify.
  • Public pricing examples are modeled or third-party figures and should not be treated as Transamerica quotes.
  • Public materials reviewed were not sufficient to verify every exclusion, contestability provision, lapse rule, or policy-form detail.
  • AI-platform agreement does not prove product quality, and no personal testing, customer experience, or independent verification was performed for this review.

Explore more life insurance guidance in the category directory.

Sources

Company-Owned Sources

  • Final Expense Solutions Portfolio: https://cloud.email.transamerica.com/final-expense/
  • Final expense life insurance - Transamerica: https://www.transamerica.com/final-expense-life-insurance
  • Transamerica Simplifies Final Expense Insurance for Consumers and Agents: https://www.transamerica.com/news/transamerica-simplifies-final-expense-insurance-consumers-and-agents
  • Transamerica Simplifies Final Expense Insurance for Consumers and Agents: https://www.transamerica.com/press-release/transamerica-simplifies-final-expense-insurance-consumers-and-agents
  • Additional AI research evidence122 records
    1. AI research evidence record openai:c1
    2. AI research evidence record anthropic:2-1
    3. AI research evidence record grok:web:1
    4. AI research evidence record kimi:palmettomutual
    5. AI research evidence record perplexity:c1
    6. AI research evidence record google:1.1.1
    7. AI research evidence record anthropic:8-3
    8. AI research evidence record anthropic:11-1
    9. AI research evidence record perplexity:c9
    10. AI research evidence record anthropic:38-1
    11. AI research evidence record anthropic:45-2
    12. AI research evidence record anthropic:45-3
    13. AI research evidence record anthropic:38-7
    14. AI research evidence record anthropic:38-5
    15. AI research evidence record openai:c1
    16. AI research evidence record anthropic:24-7
    17. AI research evidence record perplexity:c4
    18. AI research evidence record google:1.3.4
    19. AI research evidence record openai:c3
    20. AI research evidence record anthropic:2-1
    21. AI research evidence record anthropic:8-1
    22. AI research evidence record anthropic:26-1
    23. AI research evidence record grok:web:8
    24. AI research evidence record anthropic:10-3
    25. AI research evidence record anthropic:28-1
    26. AI research evidence record google:1.1.2
    27. AI research evidence record google:1.1.8
    28. AI research evidence record openai:c1
    29. AI research evidence record anthropic:24-7
    30. AI research evidence record deepseek:c1
    31. AI research evidence record grok:web:2
    32. AI research evidence record kimi:palmettomutual
    33. AI research evidence record perplexity:c4
    34. AI research evidence record google:1.3.4
    35. AI research evidence record anthropic:26-10
    36. AI research evidence record anthropic:35-10
    37. AI research evidence record grok:web:1
    38. AI research evidence record openai:c2
    39. AI research evidence record anthropic:8-3
    40. AI research evidence record anthropic:8-6
    41. AI research evidence record google:1.1.2
    42. AI research evidence record anthropic:8-4
    43. AI research evidence record deepseek:c2
    44. AI research evidence record openai:c5
    45. AI research evidence record anthropic:11-1
    46. AI research evidence record perplexity:c9
    47. AI research evidence record anthropic:11-5
    48. AI research evidence record anthropic:2-1
    49. AI research evidence record anthropic:10-3
    50. AI research evidence record google:1.1.8
    51. AI research evidence record anthropic:1-9
    52. AI research evidence record kimi:moneygeek
    53. AI research evidence record anthropic:8-8
    54. AI research evidence record anthropic:17-9
    55. AI research evidence record openai:c1
    56. AI research evidence record openai:c2
    57. AI research evidence record deepseek:c3
    58. AI research evidence record anthropic:38-1
    59. AI research evidence record anthropic:43-1
    60. AI research evidence record openai:c1
    61. AI research evidence record anthropic:8-1
    62. AI research evidence record anthropic:26-1
    63. AI research evidence record anthropic:35-10
    64. AI research evidence record anthropic:35-11
    65. AI research evidence record openai:c2
    66. AI research evidence record anthropic:8-3
    67. AI research evidence record anthropic:8-6
    68. AI research evidence record kimi:palmettomutual
    69. AI research evidence record anthropic:26-4
    70. AI research evidence record anthropic:35-4
    71. AI research evidence record anthropic:3-3
    72. AI research evidence record anthropic:3-6
    73. AI research evidence record anthropic:3-4
    74. AI research evidence record anthropic:24-1
    75. AI research evidence record openai:c2
    76. AI research evidence record deepseek:c1
    77. AI research evidence record perplexity:c2
    78. AI research evidence record anthropic:14-6
    79. AI research evidence record anthropic:11-1
    80. AI research evidence record anthropic:11-4
    81. AI research evidence record anthropic:11-5
    82. AI research evidence record anthropic:11-2
    83. AI research evidence record kimi:palmettomutual
    84. AI research evidence record openai:c5
    85. AI research evidence record anthropic:30-9
    86. AI research evidence record google:1.1.5
    87. AI research evidence record openai:c1
    88. AI research evidence record anthropic:2-1
    89. AI research evidence record openai:c2
    90. AI research evidence record anthropic:8-6
    91. AI research evidence record kimi:palmettomutual
    92. AI research evidence record deepseek:c3
    93. AI research evidence record anthropic:38-9
    94. AI research evidence record openai:c2
    95. AI research evidence record anthropic:8-4
    96. AI research evidence record deepseek:c1
    97. AI research evidence record perplexity:c2
    98. AI research evidence record openai:c1
    99. AI research evidence record anthropic:12-9
    100. AI research evidence record kimi:palmettomutual
    101. AI research evidence record anthropic:24-7
    102. AI research evidence record openai:c2
    103. AI research evidence record deepseek:c1
    104. AI research evidence record kimi:palmettomutual
    105. AI research evidence record anthropic:36-5
    106. AI research evidence record grok:web:1
    107. AI research evidence record google:1.1.5
    108. AI research evidence record openai:c1
    109. AI research evidence record anthropic:12-9
    110. AI research evidence record anthropic:30-10
    111. AI research evidence record kimi:moneygeek
    112. AI research evidence record openai:c1
    113. AI research evidence record perplexity:c4
    114. AI research evidence record anthropic:10-4
    115. AI research evidence record openai:c2
    116. AI research evidence record kimi:palmettomutual
    117. AI research evidence record anthropic:12-9
    118. AI research evidence record anthropic:8-4
    119. AI research evidence record anthropic:17-7
    120. AI research evidence record anthropic:17-9
    121. AI research evidence record anthropic:30-9
    122. AI research evidence record anthropic:30-10

Independent Sources

Other Sources

  • Transamerica Life Insurance Companies Product Guide: https://www.parrysteinborn.com/uploads/9/5/1/9/95193272/trans.pdf
  • Additional AI research evidence122 records
    1. AI research evidence record openai:c1
    2. AI research evidence record anthropic:2-1
    3. AI research evidence record grok:web:1
    4. AI research evidence record kimi:palmettomutual
    5. AI research evidence record perplexity:c1
    6. AI research evidence record google:1.1.1
    7. AI research evidence record anthropic:8-3
    8. AI research evidence record anthropic:11-1
    9. AI research evidence record perplexity:c9
    10. AI research evidence record anthropic:38-1
    11. AI research evidence record anthropic:45-2
    12. AI research evidence record anthropic:45-3
    13. AI research evidence record anthropic:38-7
    14. AI research evidence record anthropic:38-5
    15. AI research evidence record openai:c1
    16. AI research evidence record anthropic:24-7
    17. AI research evidence record perplexity:c4
    18. AI research evidence record google:1.3.4
    19. AI research evidence record openai:c3
    20. AI research evidence record anthropic:2-1
    21. AI research evidence record anthropic:8-1
    22. AI research evidence record anthropic:26-1
    23. AI research evidence record grok:web:8
    24. AI research evidence record anthropic:10-3
    25. AI research evidence record anthropic:28-1
    26. AI research evidence record google:1.1.2
    27. AI research evidence record google:1.1.8
    28. AI research evidence record openai:c1
    29. AI research evidence record anthropic:24-7
    30. AI research evidence record deepseek:c1
    31. AI research evidence record grok:web:2
    32. AI research evidence record kimi:palmettomutual
    33. AI research evidence record perplexity:c4
    34. AI research evidence record google:1.3.4
    35. AI research evidence record anthropic:26-10
    36. AI research evidence record anthropic:35-10
    37. AI research evidence record grok:web:1
    38. AI research evidence record openai:c2
    39. AI research evidence record anthropic:8-3
    40. AI research evidence record anthropic:8-6
    41. AI research evidence record google:1.1.2
    42. AI research evidence record anthropic:8-4
    43. AI research evidence record deepseek:c2
    44. AI research evidence record openai:c5
    45. AI research evidence record anthropic:11-1
    46. AI research evidence record perplexity:c9
    47. AI research evidence record anthropic:11-5
    48. AI research evidence record anthropic:2-1
    49. AI research evidence record anthropic:10-3
    50. AI research evidence record google:1.1.8
    51. AI research evidence record anthropic:1-9
    52. AI research evidence record kimi:moneygeek
    53. AI research evidence record anthropic:8-8
    54. AI research evidence record anthropic:17-9
    55. AI research evidence record openai:c1
    56. AI research evidence record openai:c2
    57. AI research evidence record deepseek:c3
    58. AI research evidence record anthropic:38-1
    59. AI research evidence record anthropic:43-1
    60. AI research evidence record openai:c1
    61. AI research evidence record anthropic:8-1
    62. AI research evidence record anthropic:26-1
    63. AI research evidence record anthropic:35-10
    64. AI research evidence record anthropic:35-11
    65. AI research evidence record openai:c2
    66. AI research evidence record anthropic:8-3
    67. AI research evidence record anthropic:8-6
    68. AI research evidence record kimi:palmettomutual
    69. AI research evidence record anthropic:26-4
    70. AI research evidence record anthropic:35-4
    71. AI research evidence record anthropic:3-3
    72. AI research evidence record anthropic:3-6
    73. AI research evidence record anthropic:3-4
    74. AI research evidence record anthropic:24-1
    75. AI research evidence record openai:c2
    76. AI research evidence record deepseek:c1
    77. AI research evidence record perplexity:c2
    78. AI research evidence record anthropic:14-6
    79. AI research evidence record anthropic:11-1
    80. AI research evidence record anthropic:11-4
    81. AI research evidence record anthropic:11-5
    82. AI research evidence record anthropic:11-2
    83. AI research evidence record kimi:palmettomutual
    84. AI research evidence record openai:c5
    85. AI research evidence record anthropic:30-9
    86. AI research evidence record google:1.1.5
    87. AI research evidence record openai:c1
    88. AI research evidence record anthropic:2-1
    89. AI research evidence record openai:c2
    90. AI research evidence record anthropic:8-6
    91. AI research evidence record kimi:palmettomutual
    92. AI research evidence record deepseek:c3
    93. AI research evidence record anthropic:38-9
    94. AI research evidence record openai:c2
    95. AI research evidence record anthropic:8-4
    96. AI research evidence record deepseek:c1
    97. AI research evidence record perplexity:c2
    98. AI research evidence record openai:c1
    99. AI research evidence record anthropic:12-9
    100. AI research evidence record kimi:palmettomutual
    101. AI research evidence record anthropic:24-7
    102. AI research evidence record openai:c2
    103. AI research evidence record deepseek:c1
    104. AI research evidence record kimi:palmettomutual
    105. AI research evidence record anthropic:36-5
    106. AI research evidence record grok:web:1
    107. AI research evidence record google:1.1.5
    108. AI research evidence record openai:c1
    109. AI research evidence record anthropic:12-9
    110. AI research evidence record anthropic:30-10
    111. AI research evidence record kimi:moneygeek
    112. AI research evidence record openai:c1
    113. AI research evidence record perplexity:c4
    114. AI research evidence record anthropic:10-4
    115. AI research evidence record openai:c2
    116. AI research evidence record kimi:palmettomutual
    117. AI research evidence record anthropic:12-9
    118. AI research evidence record anthropic:8-4
    119. AI research evidence record anthropic:17-7
    120. AI research evidence record anthropic:17-9
    121. AI research evidence record anthropic:30-9
    122. AI research evidence record anthropic:30-10

Verify this research

Check when the research was run, which platforms were included, and what supports the findings.

Study date
September 22, 2026
Platforms analyzed
7
Source records
39
Ranking mentions
6 of 7
Platform share
86%
Final consensus rank
#2

Behind the findings

Platforms in this study

  • ChatGPT
  • Claude
  • DeepSeek
  • Grok
  • Perplexity
  • Kimi
  • Gemini

Source records

25 independent · 11 company-owned · 3 unclear

Evidence support

30 direct · 9 partial

Keep in mind

Use the run research_date as the study date. Platform-reported dates are provenance metadata and do not independently prove freshness.

Technical verification details

Use this SHA-256 fingerprint to identify the source snapshot associated with this study.

dc2b5be1909a75d1b19a5ad5249f38d428eadcc8f931d7e330b722662c2be4b7